What Champions Oncology Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 69,794 | 164,199 |
| Disposed | 0 | 0 |
| Net activity | +69,794 | +164,199 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ackerman Joel | Director | Oct 15 | Exercise / conversion · M | +69,794 | $1.60 | +$112K | 1,126,333 |
| Ackerman Joel | Director | Oct 30 | Exercise / conversion · M | +94,405 | $2.10 | +$198K | 1,056,539 |
| Breitfeld Philip P. | Director | Mar 25 | Other Transaction · J | −4,150 | — | — | 5,717 |
| Ackerman Joel | Director | Oct 31 | Exercise / conversion · M | +16,667 | $5.43 | +$90.5K | 962,134 |
| Ackerman Joel | Director | Oct 31 | Exercise / conversion · M | +88,470 | $2.10 | +$186K | 945,467 |
| Mendelson Daniel Newman | Director | Jan 12 | Open-market buy · P | +1,000 | $6.50 | +$6.5K | 198,625 |
| Mendelson Daniel Newman | Director | Jan 11 | Open-market buy · P | +2,000 | $6.27 | +$12.5K | 197,625 |
| Mendelson Daniel Newman | Director | Jan 10 | Open-market buy · P | +2,944 | $6.31 | +$18.6K | 195,625 |
| Mendelson Daniel Newman | Director | Jan 09 | Open-market buy · P | +3,000 | $6.25 | +$18.8K | 192,681 |
| Mendelson Daniel Newman | Director | Jan 08 | Open-market buy · P | +1,000 | $6.15 | +$6.15K | 189,681 |
| Mendelson Daniel Newman | Director | Jan 05 | Open-market buy · P | +2,000 | $6.09 | +$12.2K | 188,681 |
| Mendelson Daniel Newman | Director | Jan 04 | Open-market buy · P | +3,000 | $6.12 | +$18.4K | 186,681 |
| Mendelson Daniel Newman | Director | Jan 03 | Open-market buy · P | +500 | $5.83 | +$2.92K | 183,681 |
| Mendelson Daniel Newman | Director | Dec 21 | Open-market buy · P | +2,500 | $4.92 | +$12.3K | 183,181 |
| Mendelson Daniel Newman | Director | Dec 20 | Open-market buy · P | +2,100 | $4.82 | +$10.1K | 180,681 |
| Mendelson Daniel Newman | Director | Dec 19 | Open-market buy · P | +5,000 | $4.75 | +$23.8K | 178,581 |
| Ackerman Joel | Director | Oct 17 | Exercise / conversion · M | +114,552 | $2.10 | +$241K | 856,997 |
| Mendelson Daniel Newman | Director | Oct 11 | Open-market buy · P | +5,000 | $6.40 | +$32K | 163,081 |
| Mendelson Daniel Newman | Director | Oct 10 | Open-market buy · P | +1,100 | $6.41 | +$7.05K | 158,081 |
| Mendelson Daniel Newman | Director | Oct 06 | Open-market buy · P | +1,530 | $6.48 | +$9.91K | 156,981 |
Loading...